NCT04863924View on ClinicalTrials.gov

Accelerating Lung Cancer Diagnosis Through Liquid Biopsy

Active, not recruitingOBSERVATIONAL
Enrollment

170

Participants

Timeline

Start Date

January 14, 2021

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Non-small Cell Lung Cancer
Interventions
DIAGNOSTIC_TEST

Liquid Biopsy

All patients will have a liquid biopsy with ctDNA molecular profiling

Trial Locations (1)

Unknown

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors
collaborator

Lung Health Foundation

UNKNOWN

collaborator

The Princess Margaret Cancer Foundation

OTHER

lead

University Health Network, Toronto

OTHER